| Mir Shithil, DPT | |
|
256 Nevada Ave, Atlantic City, NJ 08401-3927 | |
| (609) 665-3988 | |
| Not Available |
| Full Name | Mir Shithil |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 5 Years |
| Location | 256 Nevada Ave, Atlantic City, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790321065 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 40QA01903600 (New Jersey) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Life Home Therapy Llc | 1254746340 | 10 |
News Archive
An international research led by the Complutense University of Madrid has taken a further step to solve the age-related macular degeneration (AMD)-derived blidness problem with the development of the first biohybrid artificial retina built with silk fibroin and retinal cells.
As the "recycling plant" of the cell, the proteasome regulates vitally important functions. When it is inhibited, the cell chokes on its own waste. Cancer cells, in particular, are very sensitive because they need the proteasome for their uncontrolled growth. Biochemists at the Technische Universitaet Muenchen (TUM) have now identified the lead structure of a new class of drugs that attacks the proteasome in an unusual way. New medication could be developed on the basis of this previously unknown binding mechanism.
One of the key steps in developing new drugs is determining the atomic structure of its biologically active substances. This generally involves performing X-ray analyses of single crystal structures to determine the ingredient's detailed three-dimensional set-up. However, growing suitable single crystals is often a complex and time-consuming process.
Women and children who participate in the WIC program have low or inadequate intakes of several key nutrients that could be addressed with changes to the program's food packages, says a new report from the National Academies of Sciences, Engineering, and Medicine.
› Verified 7 days ago
| Provider Name | Proform Physical Therapy Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1073958351 PECOS PAC ID: 9436383114 Enrollment ID: O20131022001577 |
News Archive
An international research led by the Complutense University of Madrid has taken a further step to solve the age-related macular degeneration (AMD)-derived blidness problem with the development of the first biohybrid artificial retina built with silk fibroin and retinal cells.
As the "recycling plant" of the cell, the proteasome regulates vitally important functions. When it is inhibited, the cell chokes on its own waste. Cancer cells, in particular, are very sensitive because they need the proteasome for their uncontrolled growth. Biochemists at the Technische Universitaet Muenchen (TUM) have now identified the lead structure of a new class of drugs that attacks the proteasome in an unusual way. New medication could be developed on the basis of this previously unknown binding mechanism.
One of the key steps in developing new drugs is determining the atomic structure of its biologically active substances. This generally involves performing X-ray analyses of single crystal structures to determine the ingredient's detailed three-dimensional set-up. However, growing suitable single crystals is often a complex and time-consuming process.
Women and children who participate in the WIC program have low or inadequate intakes of several key nutrients that could be addressed with changes to the program's food packages, says a new report from the National Academies of Sciences, Engineering, and Medicine.
› Verified 7 days ago
| Provider Name | Life Home Therapy Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1467048777 PECOS PAC ID: 1254746340 Enrollment ID: O20210223002936 |
News Archive
An international research led by the Complutense University of Madrid has taken a further step to solve the age-related macular degeneration (AMD)-derived blidness problem with the development of the first biohybrid artificial retina built with silk fibroin and retinal cells.
As the "recycling plant" of the cell, the proteasome regulates vitally important functions. When it is inhibited, the cell chokes on its own waste. Cancer cells, in particular, are very sensitive because they need the proteasome for their uncontrolled growth. Biochemists at the Technische Universitaet Muenchen (TUM) have now identified the lead structure of a new class of drugs that attacks the proteasome in an unusual way. New medication could be developed on the basis of this previously unknown binding mechanism.
One of the key steps in developing new drugs is determining the atomic structure of its biologically active substances. This generally involves performing X-ray analyses of single crystal structures to determine the ingredient's detailed three-dimensional set-up. However, growing suitable single crystals is often a complex and time-consuming process.
Women and children who participate in the WIC program have low or inadequate intakes of several key nutrients that could be addressed with changes to the program's food packages, says a new report from the National Academies of Sciences, Engineering, and Medicine.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mir Shithil, DPT 256 Nevada Ave, Atlantic City, NJ 08401-3927 Ph: (609) 665-3988 | Mir Shithil, DPT 256 Nevada Ave, Atlantic City, NJ 08401-3927 Ph: (609) 665-3988 |
News Archive
An international research led by the Complutense University of Madrid has taken a further step to solve the age-related macular degeneration (AMD)-derived blidness problem with the development of the first biohybrid artificial retina built with silk fibroin and retinal cells.
As the "recycling plant" of the cell, the proteasome regulates vitally important functions. When it is inhibited, the cell chokes on its own waste. Cancer cells, in particular, are very sensitive because they need the proteasome for their uncontrolled growth. Biochemists at the Technische Universitaet Muenchen (TUM) have now identified the lead structure of a new class of drugs that attacks the proteasome in an unusual way. New medication could be developed on the basis of this previously unknown binding mechanism.
One of the key steps in developing new drugs is determining the atomic structure of its biologically active substances. This generally involves performing X-ray analyses of single crystal structures to determine the ingredient's detailed three-dimensional set-up. However, growing suitable single crystals is often a complex and time-consuming process.
Women and children who participate in the WIC program have low or inadequate intakes of several key nutrients that could be addressed with changes to the program's food packages, says a new report from the National Academies of Sciences, Engineering, and Medicine.
› Verified 7 days ago
Dolores K Wohler, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1801 Atlantic Avenue, First Floor, Atlantic City, NJ 08401 Phone: 609-547-2400 Fax: 609-486-5053 | |
Jessica Cestare, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1925 Pacific Ave Fl 5, Atlantic City, NJ 08401 Phone: 609-441-2122 | |
Seashore Physical Therapy Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1801 Atlantic Avenue, First Floor, Atlantic City, NJ 08401 Phone: 609-570-2400 Fax: 609-541-4131 | |
James M Foy, MPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 2419 Atlantic Ave, Atlantic City, NJ 08401 Phone: 609-347-9075 Fax: 609-347-8185 | |
Sarah Cifaloglio, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1801 Atlantic Ave, Atlantic City, NJ 08401 Phone: 609-570-2400 |